Medication info
Youngil Sitagliptin Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)

Youngil Sitagliptin Tablets 100 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Youngil Pharmaceutical Co., Ltd.
Appearance
Light orange, round, double convex, film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202005307 · Approved 2020.07.23 · Insurance code 649405540

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function before starting this medicine and periodically during treatment is recommended. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Youngil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication assists in improving blood sugar control for patients with type 2 diabetes in conjunction with diet and exercise. It can also be used as monotherapy, and if blood sugar control is difficult with monotherapy due to a lack of prior diabetes medication experience, it is taken in conjunction with metformin. Additionally, this medication is used when blood sugar control is insufficient with sulfonylureas, metformin, thiazolidinediones, or insulin in monotherapy. If blood sugar control is not attained with combinations of sulfonylureas and metformin, thiazolidinediones and metformin, or insulin and metformin, this medication can be added to enhance therapeutic efficacy. This combination therapy effectively improves blood sugar control.

How to take

Adult dose

This medicine is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function before starting this medicine and periodically during treatment is recommended. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Precautions

This medication may cause rare but severe allergic reactions, and if symptoms such as rash, difficulty breathing, or swelling of the face or neck occur after taking the medication, it should be discontinued immediately and a doctor consulted. During the use of this medication, acute pancreatitis may develop, so if severe abdominal pain or vomiting occurs, immediate medical attention is required. This medication should not be used by patients with type 1 diabetes or diabetic ketoacidosis, nor should it be administered to those with known allergies to this medication or its components. Patients with impaired kidney function should have their dosage adjusted, and regular kidney function tests are necessary before and during treatment. Since there is a risk of hypoglycemia, caution should be exercised for signs of low blood sugar while using this medication in conjunction with insulin or sulfonylureas, and dosage adjustments for those medications may be necessary. If severe joint pain occurs during the use of this medication, a doctor should be informed, and immediate medical attention is required for blisters or skin lesions. Pregnant or nursing women should not use this medication, and its safety and efficacy have not been established for children or adolescents under 18 years of age. Elderly patients may be at risk for diminished kidney function, so dosage adjustments and regular kidney function checks are necessary. In case of overdose, measures should be taken to remove the drug from the gastrointestinal tract, monitor the condition through ECG, and if necessary, some drug removal may be achieved through hemodialysis. Interactions with other medications taken concurrently with this medication are generally minimal, but if taking digoxin or cyclosporine, healthcare professionals should be informed for appropriate management. While using this medication, side effects such as infections, headaches, indigestion, and diarrhea may occur; if symptoms are severe or prolonged, consultation with a doctor is recommended.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 27 more
  • nausea
  • constipation
  • vomiting
  • severe arthralgia with disability
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • indigestion
  • dizziness
  • elevated serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will ensure the medication's efficacy is maintained safely.

Appearance and packaging

Appearance

Light orange, round, double convex, film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.